Home > Journals > Minerva Cardioangiologica > Past Issues > Articles online first > Minerva Cardioangiologica 2016 Nov 30

CURRENT ISSUEMINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

Minerva Cardioangiologica 2016 Nov 30

language: English

Fractional flow reserve: lessons from PLATFORM and future perspectives

Gianluca PONTONE 1, Patrizia CARITÀ 2, Massimo VERDECCHIA 3, Dario BUCCHERI 4, Daniele ANDREINI 1, 5, Andrea I. GUARICCI 6, 7, Mark RABBAT 8, 9, Mauro PEPI 1

1 Centro Cardiologico Monzino, IRCCS, Milan, Italy; 2 Department of Cardiology, San Giovanni Di Dio Hospital, Agrigento, Italy; 3 Department of Radiology, Istituto Clinico Città Studi, Milan, Italy; 4 Department of Cardiology, San Giacomo D’Altopasso Hospital, Licata (AG), Italy; 5 Department of Cardiovascular Sciences and Community Health, University of Milan, Milan, Italy; 6 Institute of Cardiovascular Disease, Department of Emergency and Organ Transplantation, University Hospital “Policlinico Consorziale” of Bari, Bari, Italy; 7 Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy; 8 Department of Medicine, Division of Cardiology, Loyola University Chicago; 9 Department of Medicine, Division of Cardiology, Edward Hines Jr. VA Hospital, Hines, IL


PDF  REPRINTS


In the treatment of stable coronary artery disease (CAD) the identification of patients who may gain the highest benefit from further invasive treatments is of pivotal importance for the healthcare system. In this setting, it has been established that an ischemia-guided revascularization strategy yields improved clinical outcomes in a cost- effective fashion compared with anatomy-guided revascularization alone. Invasive fractional flow reserve (FFR) is considered the gold standard, especially in the intermediate-range atherosclerotic lesions, for assessing lesion specific ischemia at the time of invasive coronary angiography and has now become the standard of reference for studies assessing the diagnostic performance of the various non-invasive stress tests. Coronary computed tomography angiography (cCTA) is an increasingly utilized non-invasive test that enables direct anatomical visualization of CAD in the epicardial coronary arteries with excellent sensitivity and negative predictive value. However, cCTA alone has poor specificity with FFR. With advances in computational fluid dynamics, it is possible to derive FFR from cCTA datasets improving its positive predictive value and specificity. The aim of this review is to summarize the technical aspects of FFR-CT, clinical evidence and limitations behind the novel technology, with a special focus on the recent PLATFORM trial analyzing the effectiveness, clinical outcomes and resource utilization of FFR-CT. Finally, the future perspective of FFR-CT will be presented.

top of page